Tawil R - Search Results

1

Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.

LoRusso S, Johnson NE, McDermott MP, Eichinger K, Butterfield RJ, Carraro E, Higgs K, Lewis L, Mul K, Sacconi S, Sansone VA, Shieh P, van Engelen B, Wagner K, Wang L, Statland JM, Tawil R; ReSolve Investigators and the FSHD CTRN18. LoRusso S, et al. Among authors: tawil r. BMC Neurol. 2019 Sep 10;19(1):224. doi: 10.1186/s12883-019-1452-x. BMC Neurol. 2019. PMID: 31506080 Free PMC article.

2

Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation. FSH-DY Group.

Griggs RC, Tawil R, McDermott M, Forrester J, Figlewicz D, Weiffenbach B. Griggs RC, et al. Among authors: tawil r. Muscle Nerve Suppl. 1995;2:S50-5. Muscle Nerve Suppl. 1995. PMID: 7739626

3

Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Personius KE, Pandya S, King WM, Tawil R, McDermott MP. Personius KE, et al. Among authors: tawil r. Phys Ther. 1994 Mar;74(3):253-63. doi: 10.1093/ptj/74.3.253. Phys Ther. 1994. PMID: 8115459

4

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group.

Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC. Tawil R, et al. Neurology. 1994 Mar;44(3 Pt 1):442-6. doi: 10.1212/wnl.44.3_part_1.442. Neurology. 1994. PMID: 8145913

5

Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic cases.

Griggs RC, Tawil R, Storvick D, Mendell JR, Altherr MR. Griggs RC, et al. Among authors: tawil r. Neurology. 1993 Nov;43(11):2369-72. doi: 10.1212/wnl.43.11.2369. Neurology. 1993. PMID: 8232958

6

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.

Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D. Tawil R, et al. Ann Neurol. 1996 Jun;39(6):744-8. doi: 10.1002/ana.410390610. Ann Neurol. 1996. PMID: 8651646

7

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC. Tawil R, et al. Neurology. 1997 Jan;48(1):46-9. doi: 10.1212/wnl.48.1.46. Neurology. 1997. PMID: 9008492

8

Andersen's syndrome: a distinct periodic paralysis.

Sansone V, Griggs RC, Meola G, Ptácek LJ, Barohn R, Iannaccone S, Bryan W, Baker N, Janas SJ, Scott W, Ririe D, Tawil R. Sansone V, et al. Among authors: tawil r. Ann Neurol. 1997 Sep;42(3):305-12. doi: 10.1002/ana.410420306. Ann Neurol. 1997. PMID: 9307251 Free article.

9

Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium.

Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B. Tawil R, et al. Ann Neurol. 1998 Mar;43(3):279-82. doi: 10.1002/ana.410430303. Ann Neurol. 1998. PMID: 9506542 Review.

10

Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R. Kissel JT, et al. Among authors: tawil r. Neurology. 1998 May;50(5):1402-6. doi: 10.1212/wnl.50.5.1402. Neurology. 1998. PMID: 9595995 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page